The CEO of StemExpress claimed in a new interview that her company was just collecting “maternal blood” from the abortion chain Planned Parenthood before the groups’ relationship ended in 2015.
The Sacramento Business Journal recently published a profile of Cate Dyer, the CEO of StemExpress. The California-based company is projected to make a $100 million annual revenue by 2022.
For years, it had a close partnership with the abortion chain Planned Parenthood to harvest aborted baby body parts and sell them to researchers. But after the Center for Medical Progress exposed the scandal and a swarm of negative publicity followed, StemExpress cut ties with the abortion company.
Dyer claims her biotech company’s mission is “to help save human lives” by collecting human tissue and selling it to researchers.
Absurdly, however, Dyer also claimed that her company mainly worked with Planned Parenthood to collect “maternal blood.”
According to the biased report:
Dyer’s company was even a target of highly misleading charges by anti-abortion fringe groups in 2015. It was falsely claimed that StemExpress was obtaining aborted embryos from Planned Parenthood. “It was an all part of a campaign to de-fund Planned Parenthood,” Dyer tells me in a follow-up phone call. “What we were doing with Planned Parenthood was based on (collecting) maternal blood. (We were) working for prenatal diagnostics companies to do DNA testing” on moms-to-be. The result, Dyer says, was the creation of new blood tests that greatly reduce the number of amniocentesis tests conducted — those huge-needle exams used to discover abnormalities, such as the potential for a child to be born with Down’s Syndrome, in a pregnant woman’s blood.
This report is what really is highly misleading. Dyer herself admitted that StemExpress was collecting things like aborted babies’ livers back in 2015. StemExpress was not just collecting aborted embryos, either, despite what the report claims. Later-term unborn babies whose organs were already formed and functioning were being aborted and their organs harvested.
Holly O’Donnell, a licensed phlebotomist who unsuspectingly took a job as a “procurement technician” at StemExpress in late 2012, said her StemExpress supervisor instructed her to cut through the face of the fetus in order to get the brain.
“I can’t even describe what that feels like,” she said.
In another CMV undercover video, Dyer was shown in a lunch meeting with undercover operatives posing as representatives of a biotech firm. Dyer was laughing about how StemExpress purchased fully intact aborted babies from Planned Parenthood. She laughed about how shippers of the aborted babies would give a warning to lab workers to expect such a baby.
“Oh yeah, if you have intact cases — which we’ve done a lot — we sometimes ship those back to our lab in its entirety,” she said.
“Tell the lab its coming,” she laughed about the intact unborn babies. “You know, open the box and go ‘Oh my God.’”
“What would make your lab happy?” asked one of the actors. “Another 50 livers a week,” Dyer said. “We’re working with almost like triple digit number clinics,” Dyer explained, “and we still need more.” She later noted, “Planned Parenthood has volume, because they are a volume institution.”
In a public statement, Dyer later said she was talking about intact organs, not full bodies.
The sale or purchase of human fetal tissue is a federal felony punishable by up to 10 years in prison or a fine of up to $500,000 (42 U.S.C. 289g-2). The Sacramento Business Journal reported in 2015 that StemExpress had an annual revenue of $4.5 million.